Zanolimumab
Product Specifications
UNSPSC Description
Zanolimumab (Anti-Human CD4 Recombinant Antibody) is a fully human monoclonal antibody targets CD4. Zanolimumab effectively inhibits T-cell receptor (TCR) signal transduction. Zanolimumab can be used for the research of heumatoid arthritis, psoriasis, melanoma, cutaneous and peripheral T-cell lymphoma[1].
Target Antigen
Transmembrane Glycoprotein
Type
Inhibitory Antibodies
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/zanolimumab.html
Purity
99.21
Solubility
10 mM in DMSO
Smiles
[Zanolimumab]
References & Citations
[1]Rider DA, et al. A human CD4 monoclonal antibody for the treatment of T-cell lymphoma combines inhibition of T-cell signaling by a dual mechanism with potent Fc-dependent effector activity. Cancer Res. 2007 Oct 15;67(20):9945-53.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-P99266/Zanolimumab-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-P99266/Zanolimumab-SDS-MedChemExpress.pdf
Clinical Information
Phase 3
CAS Number
652153-01-0
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6314285-01 0.2 mL
KLK14, NT (KLK14, KLKL6, Kallikrein-14, Kallikrein-like protein 6) (FITC)
Ask
View Details 
MBS6314285-02 5x 0.2 mL
KLK14, NT (KLK14, KLKL6, Kallikrein-14, Kallikrein-like protein 6) (FITC)
Ask
View Details 